2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Barrow SE et al. | Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. | 1989 | Biochim. Biophys. Acta | pmid:2679889 |
Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |
Ritter JM et al. | Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. | 1989 | Br J Clin Pharmacol | pmid:2590611 |
Ruth V et al. | Urinary excretion of prostacyclin metabolites in infants born after maternal preeclampsia or with birth asphyxia. | 1989 | Biol. Neonate | pmid:2506939 |
Fitzgerald DJ et al. | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. | 1988 | J. Clin. Invest. | pmid:3183064 |
Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
Vesterqvist O et al. | In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. | 1988 | Scand. J. Clin. Lab. Invest. | pmid:3375779 |
Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
Gréen K et al. | Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus. | 1988 | Acta Endocrinol. | pmid:3291538 |
Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
Lassila R et al. | Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. | 1988 | BMJ | pmid:3142565 |
Vericel E et al. | Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. | 1988 | Thromb. Res. | pmid:3129819 |
Minuz P et al. | Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension. | 1988 | Hypertension | pmid:3290103 |
Seyberth HW et al. | Excretion of primary prostanoids and their metabolites during acute volume expansion. | 1988 | Prostaglandins | pmid:3163156 |
Hamm CW et al. | Biochemical evidence of platelet activation in patients with persistent unstable angina. | 1987 | J. Am. Coll. Cardiol. | pmid:3668113 |
Nowak J et al. | Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. | 1987 | Am. J. Physiol. | pmid:3548440 |
Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
Neiman J et al. | Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics. | 1987 | J. Clin. Pathol. | pmid:3584500 |
Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |